MHRA set up online reporting of swine flu treatment adverse reactions

The MHRA has set up a new online reporting system to monitor suspected adverse reactions to antiviral use as the swine flu pandemic spreads.

The Swine Flu Adverse Drug Reaction Portal, accessible at www.mhra.gov.uk/swineflu, will enable GPs to quickly report suspected adverse reactions to Tamiflu and Relenza as well as future H1N1 vaccines once they have been developed.

The portal, which will remain in operation for the duration of the pandemic, will also be open to members of the public, as with the current Yellow Card Scehme.

In a letter to healthcare professionals Dr June Raine, the MHRA's director of vigilance and risk management of medicines, said: ‘The portal has been designed to make completing a report as quick and easy as possible.'

‘I recognise that this will be an especially busy time for healthcare professionals and I appreciate you extra effort to report. Remember, every report matters.'